¼¼°èÀÇ RNA ºÐ¼®(Àü»çüÇÐ) ½ÃÀå
RNA Analysis / Transcriptomics
»óǰÄÚµå : 1650737
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 02¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 504 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,464,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 25,393,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ RNA ºÐ¼®(Àü»çüÇÐ) ½ÃÀåÀº 2030³â±îÁö 190¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â ¹ÌÈ­ 89¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â RNA ºÐ¼®(Àü»çüÇÐ) ¼¼°è ½ÃÀåÀº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 13.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·ü·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â ¹ÌÈ­ 190¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. º¸°í¼­¿¡¼­ ºÐ¼® µÈ À¯Çü Áß Çϳª ÀÎ RNA ºÐ¼®(Àü»çüÇÐ) ½Ã¾à ¹× ¼Ò¸ðǰÀº 14.5 %ÀÇ CAGRÀ» ±â·ÏÇÏ°í ºÐ¼® ±â°£ÀÌ ³¡³¯ ¶§±îÁö ¹ÌÈ­ 97 ¾ï ´Þ·¯¿¡À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. RNA ºÐ¼®(Àü»çüÇÐ) ±â±â ºÎ¹®ÀÇ ¼ºÀåÀº ºÐ¼® ±â°£ µ¿¾È 11.9 % CAGR·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 33¾ï ´Þ·¯, Áß±¹Àº CAGR 14.4%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ RNA ºÐ¼®(Àü»çüÇÐ) ½ÃÀåÀº 2024³â ¹ÌÈ­ 33¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è¿¡¼­ µÎ ¹øÂ°·Î Å« °æÁ¦ ±Ô¸ð¸¦ ÀÚ¶ûÇÏ´Â Áß±¹Àº 2024-2030³â ºÐ¼® ±â°£ µ¿¾È 14.4%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» ±â·ÏÇϸç 2030³â±îÁö 16¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ µµ´ÞÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ´Ù¸¥ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ª ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ µ¿¾È °¢°¢ 11.5%¿Í 13.3%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» ±â·ÏÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. À¯·´ ³»¿¡¼­´Â µ¶ÀÏÀÌ ¾à 13.2%ÀÇ ¿¬Æò±Õ ¼ºÀå·üÀ» º¸ÀÏ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¼¼°èÀÇ RNA ºÐ¼® Àü»çüÇÐ ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ ¿ä¾à

Àü»çüÇÐÀ̶ó°íµµ ÇÏ´Â RNA ºÐ¼®Àº ¼¼Æ÷ ¶Ç´Â À¯±âü ³»ÀÇ RNA ºÐÀÚ¿¡ ´ëÇÑ ¿¬±¸¿¡ ÃÊÁ¡À» ¸ÂÃá ºÐÀÚ »ý¹°Çп¡¼­ °­·ÂÇϰí ÇʼöÀûÀÎ ºÐ¾ßÀÔ´Ï´Ù. Àü»çüÇÐÀº DNA¿Í ´Ü¹éÁú »çÀÌÀÇ Áß°£Ã¼ÀÎ RNA Àü»çÀÇ ¾ç°ú ¼­¿­À» Á¶»çÇÏ¿© À¯ÀüÀÚ ¹ßÇö°ú Á¶Àý¿¡ ´ëÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÕ´Ï´Ù. ÀÌ ºÐ¼®Àº ¼¼Æ÷ ±â´ÉÀ» ÀÌÇØÇϰí, Áúº´ÀÇ ¹ÙÀÌ¿À¸¶Ä¿¸¦ ½Äº°Çϸç, ÀáÀçÀûÀÎ Ä¡·á Ç¥ÀûÀ» ¹ß°ßÇÏ´Â µ¥ ¸Å¿ì Áß¿äÇÕ´Ï´Ù. RNA ½ÃÄö½Ì(RNA-Seq), ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, Á¤·®Àû PCR(qPCR)°ú °°Àº ±â¼úÀº ÀϹÝÀûÀ¸·Î ´Ù¾çÇÑ Á¶°ÇÀ̳ª ¹ß´Þ ´Ü°è¿¡ °ÉÃÄ RNA ¼öÁØÀ» ÃøÁ¤ÇÏ°í ºñ±³Çϱâ À§ÇØ Àü»çüÇп¡¼­ »ç¿ëµË´Ï´Ù. ÀÌ·¯ÇÑ ¹æ¹ýÀ» ÅëÇØ ¿¬±¸ÀÚµéÀº À¯ÀüÀÚ ¹ßÇö¿¡ ´ëÇÑ Æ÷°ýÀûÀÎ ÇÁ·ÎÆÄÀÏÀ» ±¸ÃàÇÏ¿© »ý¹°ÇÐÀû °úÁ¤°ú Áúº´ ¸ÞÄ¿´ÏÁòÀÇ º¹À⼺À» ¹àÈú ¼ö ÀÖ½À´Ï´Ù.

±â¼ú ¹ßÀüÀ¸·Î RNA ºÐ¼®ÀÇ ±â´É°ú ÀÀ¿ë ºÐ¾ß°¡ Å©°Ô Çâ»óµÇ¾ú½À´Ï´Ù. ƯÈ÷ °í󸮷® ½ÃÄö½Ì ±â¼ú, RNA-SeqÀº °Ô³ð Àüü¿¡ °ÉÃÄ RNA Àü»ç¸¦ Á¤È®ÇÏ°í Æ÷°ýÀûÀ¸·Î Á¤·®È­ÇÒ ¼ö ÀÖ°Ô ÇÔÀ¸·Î½á Àü»çüÇп¡ Çõ¸íÀ» ÀÏÀ¸Ä×½À´Ï´Ù. RNA-SeqÀº ±âÁ¸ ¹æ¹ý¿¡ ºñÇØ ´õ »ó¼¼ÇÏ°í Æí°ß ¾ø´Â Àü»çü ºä¸¦ Á¦°øÇÏ¿© »õ·Î¿î Àü»çü, ½ºÇöóÀ̽º º¯ÀÌü, ºñÄÚµù RNA¸¦ °ËÃâÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù. ¶ÇÇÑ ´ÜÀÏ ¼¼Æ÷ RNA ½ÃÄö½Ì(scRNA-Seq)Àº ´ÜÀÏ ¼¼Æ÷ ¼öÁØ¿¡¼­ À¯ÀüÀÚ ¹ßÇöÀ» ºÐ¼®ÇÒ ¼ö ÀÖ´Â Çõ½ÅÀûÀÎ ±â¼ú·Î ºÎ»óÇÏ¿© ¼¼Æ÷ ÀÌÁú¼º°ú ¼¼Æ÷ °úÁ¤ÀÇ ¿ªÇÐÀ» Àü·Ê ¾ø´Â ºÐÇØ´ÉÀ¸·Î ¹àÇô³»°í ÀÖ½À´Ï´Ù. °è»ê µµ±¸¿Í »ý¹°Á¤º¸ÇÐÀÇ ¹ßÀüµµ Àü»çüÇп¡¼­ Áß¿äÇÑ ¿ªÇÒÀ» ÇÏ¸ç µ¥ÀÌÅÍ ºÐ¼®, ÅëÇÕ, ÇØ¼®¿¡ ÇÊ¿äÇÑ ÇÁ·¹ÀÓ¿öÅ©¸¦ Á¦°øÇÔÀ¸·Î½á ¿¬±¸ÀÚµéÀÌ º¹ÀâÇÑ µ¥ÀÌÅÍ ¼¼Æ®¿¡¼­ ÀÇ¹Ì ÀÖ´Â »ý¹°ÇÐÀû ÀλçÀÌÆ®¸¦ µµÃâÇÒ ¼ö ÀÖ°Ô ÇØÁÝ´Ï´Ù.

°³ÀÎ ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ ¼ö¿ä Áõ°¡, ½ÃÄö½Ì ±â¼úÀÇ ¹ßÀü, ¸¸¼º Áúȯ°ú ¾ÏÀÇ À¯º´·ü Áõ°¡ µî ¿©·¯ ¿äÀο¡ ÀÇÇØ RNA ºÐ¼®(Àü»çüÇÐ) ½ÃÀåÀÇ ¼ºÀåÀÌ ÁÖµµµÇ°í ÀÖ½À´Ï´Ù. °³ÀÎÀÇ À¯ÀüÀû ÇÁ·ÎÇÊ¿¡ µû¶ó ¸ÂÃãÇü Ä¡·á¸¦ ¸ñÇ¥·Î ÇÏ´Â °³ÀÎ ¸ÂÃãÇü ÀÇÇÐÀ¸·ÎÀÇ ÀüȯÀº Áúº´º° ¹ÙÀÌ¿À¸¶Ä¿¿Í Ä¡·á Ç¥ÀûÀ» ½Äº°Çϱâ À§ÇÑ Æ÷°ýÀûÀÎ Àü»çü ºÐ¼®ÀÇ Çʿ伺À» ÃËÁøÇß½À´Ï´Ù. ½ÃÄö½Ì ±â¼úÀÇ Áö¼ÓÀûÀÎ °³¼±À¸·Î Á¤È®µµ, 󸮷®, ºñ¿ë È¿À²¼ºÀÌ ³ô¾ÆÁö¸é¼­ Àü»çü ¿¬±¸¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ´Ù¾çÇÑ ÀÀ¿ë ºÐ¾ß¿¡¼­ ½ÇÇö °¡´ÉÇØÁ³½À´Ï´Ù.¶ÇÇÑ ¸¸¼º Áúȯ°ú ¾ÏÀÇ ¹ßº´·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ÀÌ·¯ÇÑ ÁúȯÀÇ ºÐÀÚÀû Åä´ë¸¦ ÀÌÇØÇÏ´Â µ¥ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ¿¬±¸ ¹× ÀÓ»ó ȯ°æ¿¡¼­ Àü»çüÇÐÀÌ Ã¤Åõǰí ÀÖ½À´Ï´Ù. À¯ÀüüÇÐ ¿¬±¸¸¦ À§ÇÑ Á¤ºÎÀÇ ÀÌ´Ï¼ÅÆ¼ºê¿Í ÀÚ±Ý Áö¿ø, Çмú ±â°ü°ú Á¦¾à ȸ»ç °£ÀÇ Çù·Âµµ ½ÃÀå È®´ë¿¡ ±â¿©Çϰí ÀÖ½À´Ï´Ù. ±× °á°ú, RNA ºÐ¼®(Àü»çüÇÐ) ºÐ¾ß´Â »ý¹°Çп¡ ´ëÇÑ ÀÌÇØ¸¦ ³ôÀ̰í ÀÇ·á °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖ´Â Áö¼ÓÀûÀÎ Çõ½Å°ú ¾ÖÇø®ÄÉÀ̼ÇÀ» ÅëÇØ Å©°Ô ¼ºÀåÇÒ °ÍÀ¸·Î Àü¸ÁµË´Ï´Ù.

ºÎ¹®

Á¦Ç°(½Ã¾à ¹× ¼Ò¸ðǰ, Àåºñ, ¼­ºñ½º, ¼ÒÇÁÆ®¿þ¾î), ±â¼ú(ÁßÇÕ È¿¼Ò ¿¬¼â¹ÝÀÀ, ½ÃÄö½Ì, ¸¶ÀÌÅ©·Î¾î·¹ÀÌ, RNA °£¼·)

Á¶»ç ´ë»ó ±â¾÷ ¿¹

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

HBR
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global RNA Analysis / Transcriptomics Market to Reach US$19.0 Billion by 2030

The global market for RNA Analysis / Transcriptomics estimated at US$8.9 Billion in the year 2024, is expected to reach US$19.0 Billion by 2030, growing at a CAGR of 13.4% over the analysis period 2024-2030. RNA Analysis / Transcriptomics Reagents / Consumables, one of the segments analyzed in the report, is expected to record a 14.5% CAGR and reach US$9.7 Billion by the end of the analysis period. Growth in the RNA Analysis / Transcriptomics Instruments segment is estimated at 11.9% CAGR over the analysis period.

The U.S. Market is Estimated at US$3.3 Billion While China is Forecast to Grow at 14.4% CAGR

The RNA Analysis / Transcriptomics market in the U.S. is estimated at US$3.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.6 Billion by the year 2030 trailing a CAGR of 14.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 11.5% and 13.3% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 13.2% CAGR.

Global RNA Analysis / Transcriptomics Market - Key Trends & Drivers Summarized

RNA analysis, also known as transcriptomics, is a powerful and essential field in molecular biology that focuses on the study of RNA molecules within a cell or organism. Transcriptomics provides insights into gene expression and regulation by examining the quantity and sequences of RNA transcripts, which are the intermediates between DNA and proteins. This analysis is crucial for understanding cellular functions, identifying biomarkers for diseases, and discovering potential therapeutic targets. Techniques such as RNA sequencing (RNA-Seq), microarrays, and quantitative PCR (qPCR) are commonly used in transcriptomics to measure and compare RNA levels across different conditions or stages of development. These methods allow researchers to construct comprehensive profiles of gene expression, shedding light on the complexities of biological processes and disease mechanisms.

Technological advancements have significantly enhanced the capabilities and applications of RNA analysis. High-throughput sequencing technologies, particularly RNA-Seq, have revolutionized transcriptomics by enabling the precise and comprehensive quantification of RNA transcripts on a genome-wide scale. RNA-Seq provides a more detailed and unbiased view of the transcriptome compared to traditional methods, allowing for the detection of novel transcripts, splice variants, and non-coding RNAs. Additionally, single-cell RNA sequencing (scRNA-Seq) has emerged as a transformative technique that allows for the analysis of gene expression at the single-cell level, revealing cellular heterogeneity and the dynamics of cellular processes with unprecedented resolution. Advances in computational tools and bioinformatics have also played a crucial role in transcriptomics, providing the necessary frameworks for data analysis, integration, and interpretation, thus enabling researchers to derive meaningful biological insights from complex datasets.

The growth in the RNA analysis/transcriptomics market is driven by several factors, including the increasing demand for personalized medicine, advancements in sequencing technologies, and the rising prevalence of chronic diseases and cancer. The shift towards personalized medicine, which aims to tailor treatments based on an individual’s genetic profile, has spurred the need for comprehensive transcriptomic analysis to identify disease-specific biomarkers and therapeutic targets. Continuous improvements in sequencing technologies, resulting in higher accuracy, throughput, and cost-effectiveness, have made transcriptomic studies more accessible and feasible for a broader range of applications. Additionally, the rising incidence of chronic diseases and cancer has increased the focus on understanding the molecular underpinnings of these conditions, driving the adoption of transcriptomics in research and clinical settings. Government initiatives and funding for genomics research, along with collaborations between academic institutions and pharmaceutical companies, are also contributing to the market's expansion. As a result, the RNA analysis/transcriptomics field is poised for significant growth, with ongoing innovations and applications promising to enhance our understanding of biology and improve healthcare outcomes.

SCOPE OF STUDY:

The report analyzes the RNA Analysis / Transcriptomics market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Reagents / Consumables, Instruments, Services, Software); Technology (Polymerase Chain Reaction, Sequencing, Microarray, RNA Interference); Application (Drug Discovery, Toxicogenomics, Clinical Diagnostics, Comparative Transcriptomics)

Geographic Regions/Countries:

World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Rest of Europe; Asia-Pacific; Rest of World.

Select Competitors (Total 115 Featured) -

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â